Jeffrey S. Parkin

Array ( [id] => 4820510 [patent_doc_number] => 20080226651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'COMPOUNDS CAPABLE OF INHIBITING HIV-1 INFECTION' [patent_app_type] => utility [patent_app_number] => 12/074993 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9121 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226651.pdf [firstpage_image] =>[orig_patent_app_number] => 12074993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349358 [patent_doc_number] => 20090004719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Protein-protein interactions in human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 12/072390 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 27187 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004719.pdf [firstpage_image] =>[orig_patent_app_number] => 12072390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007096 [patent_doc_number] => 20110059127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'USE OF MUTANT HIV-1 PROTEASE OR SIV PROTEASE AS AN ADJUVANT' [patent_app_type] => utility [patent_app_number] => 12/918759 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4340 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059127.pdf [firstpage_image] =>[orig_patent_app_number] => 12918759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13276645 [patent_doc_number] => 10149888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-11 [patent_title] => Method of inhibiting HIV replication utilizing the P7 nucleocapsid protein [patent_app_type] => utility [patent_app_number] => 12/527235 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5150 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8306052 [patent_doc_number] => 08227586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Human polyomavirus, designated the wu virus, obtained from human respiratory secretions' [patent_app_type] => utility [patent_app_number] => 12/029390 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12978 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12029390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954880 [patent_doc_number] => 20080187904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'METAL CHELATE-LABELLED PEPETIDES' [patent_app_type] => utility [patent_app_number] => 12/026740 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5967 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187904.pdf [firstpage_image] =>[orig_patent_app_number] => 12026740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6368111 [patent_doc_number] => 20100074904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'SPECIFIC ACTIVATION OF A REGULATORY T CELL AND ITS USE FOR TREATMENT OF ASTHMA, ALLERGIC DISEASE, AUTOIMMUNE DISEASE, GRAFT REJECTION AND FOR TOLERANCE INDUCTION' [patent_app_type] => utility [patent_app_number] => 12/525142 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17360 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074904.pdf [firstpage_image] =>[orig_patent_app_number] => 12525142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642083 [patent_doc_number] => 08367061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs)' [patent_app_type] => utility [patent_app_number] => 12/524816 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11280 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845505 [patent_doc_number] => 20080181913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Sugar immunogens' [patent_app_type] => utility [patent_app_number] => 12/010654 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6104 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181913.pdf [firstpage_image] =>[orig_patent_app_number] => 12010654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807482 [patent_doc_number] => 20080171060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Modulation of immune response and methods based thereon' [patent_app_type] => utility [patent_app_number] => 12/011581 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13228 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171060.pdf [firstpage_image] =>[orig_patent_app_number] => 12011581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592501 [patent_doc_number] => 20100048407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS' [patent_app_type] => utility [patent_app_number] => 12/522838 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3283 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048407.pdf [firstpage_image] =>[orig_patent_app_number] => 12522838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637406 [patent_doc_number] => 20100173861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'COMBINATIONAL PARADIGM COMBATING HIV, HIV/HSV, OR HIV/HPV INFECTIONS IN HUMANS USING SMALL MOLECULAR WEIGHT COMPOUNDS FROM PLANTS' [patent_app_type] => utility [patent_app_number] => 12/523513 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10094 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173861.pdf [firstpage_image] =>[orig_patent_app_number] => 12523513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992568 [patent_doc_number] => 20110014221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'HIV COMBINATION VACCINE AND PRIME BOOST' [patent_app_type] => utility [patent_app_number] => 12/522848 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16025 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014221.pdf [firstpage_image] =>[orig_patent_app_number] => 12522848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228884 [patent_doc_number] => 20100183622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'VPR FUNCTION AND ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/971792 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31677 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183622.pdf [firstpage_image] =>[orig_patent_app_number] => 11971792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11859231 [patent_doc_number] => 09738905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Vector for expressing NC protein of HIV and method for producing NC protein using the same' [patent_app_type] => utility [patent_app_number] => 12/520147 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5663 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571446 [patent_doc_number] => 08338089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity' [patent_app_type] => utility [patent_app_number] => 11/984672 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 10874 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11984672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340217 [patent_doc_number] => 20100247570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'High Mannose Glycoprotein Epitopes' [patent_app_type] => utility [patent_app_number] => 12/514312 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7224 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247570.pdf [firstpage_image] =>[orig_patent_app_number] => 12514312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4892975 [patent_doc_number] => 20080102073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Antigen-Antibody Complexes as HIV-1 Vaccines' [patent_app_type] => utility [patent_app_number] => 11/929015 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10154 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102073.pdf [firstpage_image] =>[orig_patent_app_number] => 11929015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080126 [patent_doc_number] => 20110142847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41' [patent_app_type] => utility [patent_app_number] => 11/928612 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15067 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142847.pdf [firstpage_image] =>[orig_patent_app_number] => 11928612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368572 [patent_doc_number] => 20090306131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/927262 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17414 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306131.pdf [firstpage_image] =>[orig_patent_app_number] => 11927262 [rel_patent_id] =>[rel_patent_doc_number] =>)